SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Quadmedicine Seeks Phase 1 Trial Approval for Osteoporosis Patch

Quadmedicine applied to South Korea’s Ministry of Food and Drug Safety on October 29, 2026, for approval to conduct a Phase 1 trial of its osteoporosis treatment TeriQ Patch.

Related stories